Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Biallelic inactivation of BRCA2 in Fanconi anemia.

Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD.

Science. 2002 Jul 26;297(5581):606-9. Epub 2002 Jun 13.

2.

Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.

Hussain S, Witt E, Huber PA, Medhurst AL, Ashworth A, Mathew CG.

Hum Mol Genet. 2003 Oct 1;12(19):2503-10. Epub 2003 Aug 5.

PMID:
12915460
3.

Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.

Godthelp BC, van Buul PP, Jaspers NG, Elghalbzouri-Maghrani E, van Duijn-Goedhart A, Arwert F, Joenje H, Zdzienicka MZ.

Mutat Res. 2006 Oct 10;601(1-2):191-201. Epub 2006 Aug 21.

PMID:
16920162
4.

Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.

Yamamoto K, Ishiai M, Matsushita N, Arakawa H, Lamerdin JE, Buerstedde JM, Tanimoto M, Harada M, Thompson LH, Takata M.

Mol Cell Biol. 2003 Aug;23(15):5421-30.

5.

Breast cancer and Fanconi anemia: what are the connections?

Zdzienicka MZ, Arwert F.

Trends Mol Med. 2002 Oct;8(10):458-60.

PMID:
12383764
6.

A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.

Meyer S, Fergusson WD, Oostra AB, Medhurst AL, Waisfisz Q, de Winter JP, Chen F, Carr TF, Clayton-Smith J, Clancy T, Green M, Barber L, Eden OB, Will AM, Joenje H, Taylor GM.

Genes Chromosomes Cancer. 2005 Apr;42(4):404-15.

PMID:
15645491
7.
8.

Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.

Koren-Michowitz M, Friedman E, Gershoni-Baruch R, Brok-Simoni F, Patael Y, Rechavi G, Amariglio N.

Am J Hematol. 2005 Mar;78(3):203-6.

9.

Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.

Adachi D, Oda T, Yagasaki H, Nakasato K, Taniguchi T, D'Andrea AD, Asano S, Yamashita T.

Hum Mol Genet. 2002 Dec 1;11(25):3125-34.

PMID:
12444097
10.

Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.

Seal S, Barfoot R, Jayatilake H, Smith P, Renwick A, Bascombe L, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N; Breast Cancer Susceptibility Collaboration..

Cancer Res. 2003 Dec 15;63(24):8596-9.

11.

Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.

Bouchlaka C, Abdelhak S, Amouri A, Ben Abid H, Hadiji S, Frikha M, Ben Othman T, Amri F, Ayadi H, Hachicha M, Rebaï A, Saad A, Dellagi K; Tunisian Fanconi Anemia Study Group..

J Hum Genet. 2003;48(7):352-61. Epub 2003 Jun 24.

PMID:
12827451
12.

Cross-links between Fanconi anaemia and BRCA2.

West SC.

DNA Repair (Amst). 2003 Feb 3;2(2):231-4.

PMID:
12531392
13.

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD.

Mol Cell. 2001 Feb;7(2):249-62.

14.

Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.

Pejovic T, Yates JE, Liu HY, Hays LE, Akkari Y, Torimaru Y, Keeble W, Rathbun RK, Rodgers WH, Bale AE, Ameziane N, Zwaan CM, Errami A, Thuillier P, Cappuccini F, Olson SB, Cain JM, Bagby GC Jr.

Cancer Res. 2006 Sep 15;66(18):9017-25.

15.

Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.

Ikeda H, Matsushita M, Waisfisz Q, Kinoshita A, Oostra AB, Nieuwint AW, De Winter JP, Hoatlin ME, Kawai Y, Sasaki MS, D'Andrea AD, Kawakami Y, Joenje H.

Cancer Res. 2003 May 15;63(10):2688-94.

16.

Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9.

Nakanishi K, Moran A, Hays T, Kuang Y, Fox E, Garneau D, Montes de Oca R, Grompe M, D'Andrea AD.

Exp Hematol. 2001 Jul;29(7):842-9.

PMID:
11438206
17.

Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, Meyn MS, Grompe M.

Genes Dev. 2003 Aug 15;17(16):2021-35. Epub 2003 Jul 31.

18.

siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.

Bruun D, Folias A, Akkari Y, Cox Y, Olson S, Moses R.

DNA Repair (Amst). 2003 Sep 18;2(9):1007-13.

PMID:
12967657
19.

Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.

Noll M, Battaile KP, Bateman R, Lax TP, Rathbun K, Reifsteck C, Bagby G, Finegold M, Olson S, Grompe M.

Exp Hematol. 2002 Jul;30(7):679-88.

PMID:
12135664
20.

Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.

Gallmeier E, Hucl T, Calhoun ES, Cunningham SC, Bunz F, Brody JR, Kern SE.

Cancer Biol Ther. 2007 May;6(5):654-60. Epub 2007 Feb 7.

PMID:
17387268

Supplemental Content

Support Center